Inventage Lab Documents
Documents
0
Ticker
389470.KQ
ISIN
KR7389470006
Inventage Lab SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
Inventage Lab Documents 2026
This page contains all official documents and SEC filings for Inventage Lab stock (389470.KQ, ISIN: KR7389470006). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of Inventage Lab's regulatory filings.
Inventage Lab Stock analysis
Inventage Lab Inventage Lab Inc, based in Seongnam, South Korea, operates in the Health Care sector within Biotechnology. The company develops and commercializes human medicines for conditions including male pattern baldness, dementia, and prostate cancer, alongside veterinary medicines such as combination drugs and chemical castration agents. Founded with a focus on long-acting injection platforms and genetic material delivery systems, Inventage Lab employs 66 staff and went public on 22 November 2022.